Home|Journals|Articles by Year

Directory for Medical Articles
 

Research Article

EEO. 2020; 19(4): 2762-2765


MANAGEMENT OF OLIGOZOOSPERMIA BY APATYAKAR GHRUT: A CASE REPORT

DR. PRASAD KULKARNI, DR. SHAILESH DESHPANDE.


Abstract

Infertility is a national embarrassment in many parts of India, overwhelmed by illiteracy andlower socioeconomic expectations. Latest studies have shown that the prevalence of oligozoospermia is exceptionally high in the metropolis as well as in smaller cities in India. It affects the internal harmony, conjugal life and social functioning of those involved. Infertility is theinability of a sexually active, non-contraceptive pair to have spontaneous conception in one year.Oligospermia is one of the key factors in male infertility and is characterised as a subnormal concentration of sperm in the penile ejaculate, i.e. less than 20 million per ml. The different drugsare mentioned to encourage fertility, and may be used to treat certain types of cases. Since the condition is still unresolved and there is no full cure available. This patient was treated with oral medicine of Apatyakar Ghrut at a dose of 10 ml orally twice days before food containing lukewarm water as Anupana for a period of two months. Following administration of Apatykar Ghrut, there is a marked improvement in all symptoms of Olisozoospermia and in various semen examination such as sperm count, sperm motility, semen length, pHand liquefaction time within afew days.

Key words: Apatyakar Ghrut, Ksheen Shukra, Male Infertility, Oligozoospermia






Full-text options


Share this Article



Online Article Submission
• ejmanager.com
• ojshosting.net







Do you want to use OJS for your journal ?
work with an experienced partner
www.OJSHosting.net

eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.